News
Zacks Investment Research on MSN9d
Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold?
Tempus AI’s TEM stock has surged nearly 13% since its second-quarter 2025 earnings release. The quarter saw strong top-line ...
In addition to Stifel Nicolaus, Tempus AI, Inc. Class A also received a Hold from Piper Sandler’s David Westenberg in a report issued today. However, on August 8, Needham reiterated a Buy rating on ...
In a report released today, Rachel Vatnsdal from J.P. Morgan maintained a Hold rating on Tempus AI, Inc. Class A, with a price target of $60.00. The company’s shares closed last Friday at $60.87. Take ...
TipRanks on MSN14d
TEM Earnings: Tempus AI Stock (TEM) ‘Hitting its Stride’ on Soaring AI Drug Demand
Shares in health technology group Tempus AI ($TEM) raced 7% higher today after its Q2 revenues surged on cancer testing demand. Forecast Busting ...
Tempus AI, a stock tied to former House Speaker Nancy Pelosi, is facing fresh skepticism on Wall Street despite its strong ...
Zacks.com on MSN14d
Compared to Estimates, Tempus (TEM) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Tempus (TEM) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback